Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Topical intranasal corticosteroids in 4-11 year old children with persistent bilateral otitis media with effusion in primary care: double blind randomised placebo controlled trial.

Williamson I, Benge S, Barton S, Petrou S, Letley L, Fasey N, Haggard M, Little P.

BMJ. 2009 Dec 16;339:b4984. doi: 10.1136/bmj.b4984.

2.

A double-blind randomised placebo-controlled trial of topical intranasal corticosteroids in 4- to 11-year-old children with persistent bilateral otitis media with effusion in primary care.

Williamson I, Benge S, Barton S, Petrou S, Letley L, Fasey N, Abangma G, Dakin H, Little P.

Health Technol Assess. 2009 Aug;13(37):1-144. doi: 10.3310/hta13370.

3.

Cost-utility analysis of topical intranasal steroids for otitis media with effusion based on evidence from the GNOME trial.

Petrou S, Dakin H, Abangma G, Benge S, Williamson I.

Value Health. 2010 Aug;13(5):543-51. doi: 10.1111/j.1524-4733.2010.00711.x. Epub 2010 Mar 22.

4.

A double-blind randomized placebo-controlled trial of topical intranasal mometasone furoate nasal spray in children of adenoidal hypertrophy with otitis media with effusion.

Bhargava R, Chakravarti A.

Am J Otolaryngol. 2014 Nov-Dec;35(6):766-70. doi: 10.1016/j.amjoto.2014.06.006. Epub 2014 Jun 20.

PMID:
25151658
5.

Antibiotics for otitis media with effusion in children.

van Zon A, van der Heijden GJ, van Dongen TM, Burton MJ, Schilder AG.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD009163. doi: 10.1002/14651858.CD009163.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;(6):CD009163.

PMID:
22972136
6.

Intranasal beclomethasone as an adjunct to treatment of chronic middle ear effusion.

Tracy JM, Demain JG, Hoffman KM, Goetz DW.

Ann Allergy Asthma Immunol. 1998 Feb;80(2):198-206.

PMID:
9494455
7.

Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children.

Butler CC, Van Der Voort JH.

Cochrane Database Syst Rev. 2002;(4):CD001935. Review. Update in: Cochrane Database Syst Rev. 2006;(3):CD001935.

PMID:
12519563
8.

An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care.

Williamson I, Vennik J, Harnden A, Voysey M, Perera R, Breen M, Bradley B, Kelly S, Yao G, Raftery J, Mant D, Little P.

Health Technol Assess. 2015 Sep;19(72):1-150. doi: 10.3310/hta19720.

9.

Double-blind randomised trial of co-amoxiclav versus placebo for persistent otitis media with effusion in general practice.

van Balen FA, de Melker RA, Touw-Otten FW.

Lancet. 1996 Sep 14;348(9029):713-6.

PMID:
8806290
10.

Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial.

Tapiainen T, Kujala T, Renko M, Koivunen P, Kontiokari T, Kristo A, Pokka T, Alho OP, Uhari M.

JAMA Pediatr. 2014 Jul;168(7):635-41. doi: 10.1001/jamapediatrics.2013.5311.

PMID:
24797294
11.

The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy.

Cengel S, Akyol MU.

Int J Pediatr Otorhinolaryngol. 2006 Apr;70(4):639-45. Epub 2005 Sep 16.

PMID:
16169093
12.

Different types of intranasal steroids for chronic rhinosinusitis.

Chong LY, Head K, Hopkins C, Philpott C, Burton MJ, Schilder AG.

Cochrane Database Syst Rev. 2016 Apr 26;4:CD011993. doi: 10.1002/14651858.CD011993.pub2. Review.

PMID:
27115215
13.

Mapping analyses to estimate health utilities based on responses to the OM8-30 Otitis Media Questionnaire.

Dakin H, Petrou S, Haggard M, Benge S, Williamson I.

Qual Life Res. 2010 Feb;19(1):65-80. doi: 10.1007/s11136-009-9558-z. Epub 2009 Nov 26.

PMID:
19941078
14.

Oral steroids for the resolution of otitis media with effusion (OME) in children (OSTRICH): study protocol for a randomised controlled trial.

Waldron CA, Thomas-Jones E, Cannings-John R, Hood K, Powell C, Roberts A, Tomkinson A, Fitzsimmons D, Gal M, Harris D, Shepherd V, Butler CC, Francis N.

Trials. 2016 Mar 1;17(1):115. doi: 10.1186/s13063-016-1236-1.

15.

Systemic steroid for chronic otitis media with effusion in children.

Mandel EM, Casselbrant ML, Rockette HE, Fireman P, Kurs-Lasky M, Bluestone CD.

Pediatrics. 2002 Dec;110(6):1071-80.

PMID:
12456902
16.

Systemic and topical antibiotics for chronic rhinosinusitis.

Head K, Chong LY, Piromchai P, Hopkins C, Philpott C, Schilder AG, Burton MJ.

Cochrane Database Syst Rev. 2016 Apr 26;4:CD011994. doi: 10.1002/14651858.CD011994.pub2. Review.

PMID:
27113482
17.

Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children.

Simpson SA, Lewis R, van der Voort J, Butler CC.

Cochrane Database Syst Rev. 2011 May 11;(5):CD001935. doi: 10.1002/14651858.CD001935.pub3. Review.

PMID:
21563132
18.

A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis.

Stjärne P, Mösges R, Jorissen M, Passàli D, Bellussi L, Staudinger H, Danzig M.

Arch Otolaryngol Head Neck Surg. 2006 Feb;132(2):179-85.

PMID:
16490876
19.

[The possibilities for the treatment of exudative otitis media in the children presenting with chronic adenoiditis].

Karpova EP, Karpycheva IE, Tulupov DA.

Vestn Otorinolaringol. 2014;(6):57-60. doi: 10.17116/otorino2014657-60. Russian.

PMID:
25734311
20.

Antibiotics for otitis media with effusion in children.

Venekamp RP, Burton MJ, van Dongen TM, van der Heijden GJ, van Zon A, Schilder AG.

Cochrane Database Syst Rev. 2016 Jun 12;(6):CD009163. doi: 10.1002/14651858.CD009163.pub3. Review.

PMID:
27290722

Supplemental Content

Support Center